Macrophage migration inhibitory factor (MIF) is a multi-functional cytokine associated with inflammation and inflammatory bowel disease (IBD). The association between MIF-173G/C polymorphism and IBD risk has been extensively investigated. However, the results were conflicted and inconclusive. Therefore, we performed this meta-analysis. Online electronic databases (PubMed and EMBASE) was searched. All statistical tests were performed with the software STATA version 11.0 (Stata Corporation, College station, TX, USA). A total of nine studies (ten cohorts) with 3436 cases and 2742 controls were included for this meta-analysis. MIF-173G/C polymorphism was associated with a significantly increased risk of IBD when compared with CG and GG genotypes (OR=1.43; 95% CI 1.08-1.90; I(2) =0%). In the subgroup analysis according to ethnicity, significantly increased IBD risk was observed in Asians (OR=1.74; 95% CI 1.10-2.74; I(2) =0%) but not in Caucasians (OR=1.27; 95% CI 0.89-1.82; I(2) =0%). In the subgroup analysis according to IBD type, significantly increased UC risk was observed (OR=1.43; 95% CI 1.04-1.95; I(2) =0%). In conclusion, this meta-analysis suggested that MIF-173G/C polymorphism was associated with increased IBD risk.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537990 | PMC |
Publication Analysis
Top Keywords
Similar Publications
Preoperative Nutrition Status Predicts Hospital Length of Stay and Unplanned Reoperation Risk in Pediatric Patients With Inflammatory Bowel Disease.
J Pediatr Surg
December 2024
Department of Surgery, Indiana University, Indianapolis, IN 46202, USA; Division of Pediatric Surgery, Riley Children's Health, Indianapolis, IN 46202, USA. Electronic address:
Introduction: Many pediatric inflammatory bowel disease (IBD) patients require surgical intervention during their lifetime. Poor nutrition status correlates with adverse surgical outcomes in the adult population. A paucity of data exists on the association of preoperative nutrition status and postoperative outcomes in the pediatric population.
View Article and Find Full Text PDFAutoimmune diseases and risk of gastrointestinal cancer: an umbrella review of meta-analyses of observational studies.
Int J Surg
January 2025
Department of Surgical Oncology, Fourth Affiliated Hospital of China Medical University.
Background: Several autoimmune diseases (ADs) are considered risk factors for gastrointestinal (GI) cancers. This study pooled and appraised the evidence associating ADs to GI cancer risks.
Methods: Three databases were examined from initiation through 26 January 2024.
FAecal micRobiota transplantation in primary sclerosinG chOlangitis (FARGO): study protocol for a randomised, multicentre, phase IIa, placebo-controlled trial.
BMJ Open
January 2025
National Institute of Health and Care Research (NIHR) Birmingham Biomedical Research Centre (BRC) Center for Liver and Gastrointestinal Research, University of Birmingham, Birmingham, England, UK
Introduction: Primary sclerosing cholangitis (PSC) is the classical hepatobiliary manifestation of inflammatory bowel disease (IBD). The strong association between gut and liver inflammation has driven several pathogenic hypotheses to which the intestinal microbiome is proposed to contribute. Pilot studies of faecal microbiota transplantation (FMT) in PSC and IBD are demonstrated to be safe and associated with increased gut bacterial diversity.
View Article and Find Full Text PDFClonal Hematopoiesis of Indeterminate Potential in Crohn's Disease and Ulcerative Colitis.
Inflamm Bowel Dis
January 2025
Department of Genetics and Genomics, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Pl, Box 1498, New York, NY 10029, USA.
Background: Clonal hematopoiesis of indeterminate potential (CHIP) is the presence of somatic mutations in myeloid and lymphoid malignancy genes in the blood cells of individuals without a hematologic malignancy. Inflammation is hypothesized to be a key mediator in the progression of CHIP to hematologic malignancy and patients with CHIP have a high prevalence of inflammatory diseases. This study aimed to identify the prevalence and characteristics of CHIP in patients with inflammatory bowel disease (IBD).
View Article and Find Full Text PDFRadiation exposure in patients with inflammatory bowel disease.
J Crohns Colitis
January 2025
Translational Research in Gastrointestinal Disorders (TARGID), Department of Chronic Diseases and Metabolism, KU Leuven, Leuven, Belgium and Department of Gastroenterology and Hepatology, University Hospitals Leuven, Belgium.
Background And Aims: Radiological imaging is crucial for diagnosing and monitoring patients with inflammatory bowel diseases (IBD). With increasing awareness of radiation risks, imaging doses should be 'as low as reasonably achievable', with a risk level that one should try to stay underneath 75 mSv. However, real-world data on cumulative exposure are limited.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!